ATE505463T1 - Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten - Google Patents

Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten

Info

Publication number
ATE505463T1
ATE505463T1 AT03010776T AT03010776T ATE505463T1 AT E505463 T1 ATE505463 T1 AT E505463T1 AT 03010776 T AT03010776 T AT 03010776T AT 03010776 T AT03010776 T AT 03010776T AT E505463 T1 ATE505463 T1 AT E505463T1
Authority
AT
Austria
Prior art keywords
alkyl
groups
receptor antagonists
atoms
benzodiazepine derivatives
Prior art date
Application number
AT03010776T
Other languages
English (en)
Inventor
Hamish Ryder
Graeme Semple
David Alan Kendrick
Michael Szelke
Masato Satoh
Mitsuaki Ohta
Keiji Miyata
Akito Nishida
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE505463T1 publication Critical patent/ATE505463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
AT03010776T 1992-02-27 1993-02-26 Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten ATE505463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9204221A GB2264492B (en) 1992-02-27 1992-02-27 Benzodiazepine derivatives
GB929212740A GB9212740D0 (en) 1992-02-27 1992-06-16 Benzodiazephine derivatives

Publications (1)

Publication Number Publication Date
ATE505463T1 true ATE505463T1 (de) 2011-04-15

Family

ID=10711162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03010776T ATE505463T1 (de) 1992-02-27 1993-02-26 Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten

Country Status (7)

Country Link
EP (1) EP1342719B1 (de)
KR (1) KR100282587B1 (de)
AT (1) ATE505463T1 (de)
DE (1) DE69334353D1 (de)
ES (1) ES2364637T3 (de)
GB (2) GB2264492B (de)
ZA (1) ZA931381B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315494D0 (en) * 1993-07-27 1993-09-08 Springer Caroline Improvements relating to prodrugs
GB2282594A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
GB2282595A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) * 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
CA2026856A1 (en) * 1989-10-05 1991-04-06 Mark G. Bock 3-substituted-1,4-benzodiazepines useful as oxytocin
CA2032427A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepines analogs
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
US4994258A (en) 1990-03-05 1991-02-19 Merck & Co., Inc. Gamma emitting, CCK-A antagonists for pancreatic imaging
US5218115A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
US5218114A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
FR2682381B1 (fr) * 1991-10-10 1995-04-07 Rhone Poulenc Rorer Sa Derives de benzodiazepine, leur preparation et les medicaments les contenant.
WO1993008175A1 (en) * 1991-10-24 1993-04-29 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin

Also Published As

Publication number Publication date
EP1342719A1 (de) 2003-09-10
DE69334353D1 (de) 2011-05-26
GB9204221D0 (en) 1992-04-08
ES2364637T3 (es) 2011-09-08
EP1342719B1 (de) 2011-04-13
KR100282587B1 (ko) 2001-02-15
ZA931381B (en) 1993-12-15
GB2264492A (en) 1993-09-01
GB2264492B (en) 1996-09-25
GB2264492A8 (de) 1996-07-29
GB9212740D0 (en) 1992-07-29
KR950700225A (ko) 1995-01-16

Similar Documents

Publication Publication Date Title
EA199800908A1 (ru) Производные индола, полезные в качестве антагонистов рецептора эндотелина
DE69131581T2 (de) 2-Oxindolderivate als Tyrosinekinaseinhibitoren
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
KR950032145A (ko) 다치환된 3-아실아미노-5-페닐-1,4-벤조디아제핀-2-온 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물
ES2104865T3 (es) Nuevos derivados de n-ciclohexilbenzamidas, sus preparaciones y sus aplicaciones terapeuticas.
ATE224371T1 (de) N-substituierte beta-aryl und beta-heteroaryl- alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren
CA2129990A1 (en) Benzodiazepin derivatives useful as cck-receptor antagonists
IL125982A0 (en) 2-(arylphenyl) amino-imidazoline derivatives
ATE505463T1 (de) Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten
EP0591529A4 (de) Neues benzodiazepinderivat.
DE69430839D1 (de) Trizyklische Indol-2-carbonsäure Derivate als selektive NMDA Rezeptor Antagonisten
ES2173167T3 (es) Derivados de benzodiazepina.
EA199800720A1 (ru) Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора
ES2124771T3 (es) Derivados de 3-oxadiazolil-1,6-naftiridina con una afinidad para los receptores de benzodiazepina.
DK369289D0 (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
PT92494A (pt) Processo para a preparacao de novos derivados do indol
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions
TW327636B (en) Heterocyclic ring-fused pyrimidine derivatives
NO308304B1 (no) Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties